Previous Close | 5.4000 |
Open | 5.3500 |
Bid | 4.5000 |
Ask | 4.7000 |
Strike | 82.50 |
Expire Date | 2024-06-21 |
Day's Range | 4.9000 - 5.3500 |
Contract Range | N/A |
Volume | |
Open Interest | 642 |
NYON, Switzerland, May 08, 2024--Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.*
Toda's Research Daily features new research reports on 16 major stocks, including Salesforce, Inc. (CRM), BP p.l.c. (BP) and The Southern Company (SO).
ALC vs. EW: Which Stock Is the Better Value Option?